Dr Reddys Laboratories (RDY) Shares Outstanding (2009 - 2026)

Dr Reddys Laboratories has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $834.7 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.02% year-over-year to $834.7 million in Q1 2026; TTM through Mar 2026 was $834.7 million, a 0.02% change from a year earlier, with the FY2026 full-year figure at $834.7 million, changed 0.02% from the prior year.
• Shares Outstanding (Entity) was $834.7 million for Q1 2026 at Dr Reddys Laboratories, roughly flat from $834.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $834.7 million in Q1 2026, with the low at $832.1 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $833.6 million, with a median of $834.1 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) gained 0.17% in 2024, then rose 0.02% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $832.1 million in 2022, then grew by 0.06% to $832.6 million in 2023, then gained by 0.17% to $834.1 million in 2024, then climbed by 0.04% to $834.5 million in 2025, then gained by 0.02% to $834.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $834.7 million (Q1 2026), $834.5 million (Q1 2025), and $834.1 million (Q1 2024), per Business Quant data.